DHODH and melanoma: Supplementation elicited no rescue of cell viability in the case of tenovin 6 treatment despite the partial ablation of p53 transcriptional activation, suggesting that DHODH inhibition is not the main mechanism by which tenovin 6 kills melanoma cells.